epl oil acquired energy xxi 23 bln
dow 028 pct sp 02 pct nasdaq 011 pct
new york march 12 reuters us stocks little changed wednesday equities recouped much earlier declines amid signs progress diplomatic attempts ease tensions ukraine
stocks pressured concerns weakening economy china london copper prices seen proxy economic health due broad industrial use rebounded hitting lowest level since july 2010
us secretary state john kerry meet russian counterpart sergei lavrov london friday ahead sunday referendum whether ukraines crimean peninsula join russia go independent legality referendum disputed
however money sidelines investors worried missing another fiveyear us equity bull market keeping indexes near recent highs analysts say
situation ukraine slowing china going matter havent mattered yet commodity prices falling tied demand said kim forrest senior equity research analyst fort pitt capital group pittsburgh
people think missed market going last year said theres retail money flowing system supporting stocks
dow jones industrial average fell points 028 percent sp 500 lost 381 points 02 percent nasdaq composite added points 011 percent
geopolitical developments moved forefront week vacuum major corporate results economic data sp 500 closed record high last friday
weve climbed far continue climb definitely going seesaw move said rick meckler president libertyview capital management jersey city new jersey
herbalife fell 75 percent company said us federal trade commission opened inquiry operations shares briefly fell much 16 percent
shares fannie mae freddie mac fell sharply wednesday day leaders senate banking committee announced agreement legislation wind governmentowned mortgage financiers fannie lost 99 percent 363 freddie fell 158 percent 340
epl oil gas inc jumped 298 percent 3779 company agreed acquired larger rival energy xxi ltd 23 billion including debt energy xxi shares lost 64 percent
express inc dropped 128 percent apparel retailer reported fourthquarter earnings forecast profit current quarter fell far short analyst expectations
oxigene inc surged 715 percent 415 company said experimental drug zybrestat combined roches cancer drug avastin significantly slowed progression recurrent ovarian cancer better avastin alone midstage clinical trial
geron corp plunged 618 percent 168 company said us food drug administration ordered halt trials cancer drug concerns potential liver damage
